|
Market Closed -
Bombay S.E.
06:02:22 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 1,177.80 INR | +0.24% |
|
+0.24% | -7.34% |
Company Valuation: Dr. Reddy's Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 714,500 | 767,655 | 1,024,969 | 953,168 | 1,044,616 | 981,089 | - | - |
| Change | - | 7.44% | 33.52% | -7.01% | 9.59% | -6.08% | - | - |
| Enterprise Value (EV) 1 | 703,980 | 719,330 | 960,383 | 928,633 | 1,011,902 | 949,507 | 929,471 | 899,034 |
| Change | - | 2.18% | 33.51% | -3.31% | 8.97% | -6.17% | -2.11% | -3.27% |
| P/E | 30.4x | 17.1x | 18.4x | 16.9x | 24.4x | 26x | 20.2x | 17x |
| PBR | 3.76x | 3.33x | 3.63x | 2.86x | 2.78x | 2.41x | 2.18x | 1.98x |
| PEG | - | 0.2x | 0.8x | 13.12x | -1x | -2.2x | 0.7x | 0.9x |
| Capitalization / Revenue | 3.33x | 3.11x | 3.67x | 2.93x | 3.11x | 2.79x | 2.5x | 2.27x |
| EV / Revenue | 3.28x | 2.92x | 3.44x | 2.85x | 3.01x | 2.7x | 2.37x | 2.08x |
| EV / EBITDA | 13.7x | 11.1x | 12.1x | 10.8x | 15.1x | 15.3x | 11.6x | 9.8x |
| EV / EBIT | 20.5x | 13.8x | 14.8x | 13.4x | 21.8x | 22.8x | 16.2x | 13.4x |
| EV / FCF | 52.3x | 15.1x | 33.1x | 49.1x | 30.3x | 23.9x | 25.6x | 18.6x |
| FCF Yield | 1.91% | 6.61% | 3.02% | 2.04% | 3.3% | 4.18% | 3.9% | 5.37% |
| Dividend per Share 2 | 6 | 8 | 8 | 8 | 8 | 7.63 | 8.444 | 9.156 |
| Rate of return | 0.7% | 0.87% | 0.65% | 0.7% | 0.64% | 0.65% | 0.72% | 0.78% |
| EPS 2 | 28.34 | 54.18 | 66.92 | 67.78 | 51.42 | 45.26 | 58.31 | 69.18 |
| Distribution rate | 21.2% | 14.8% | 12% | 11.8% | 15.6% | 16.9% | 14.5% | 13.2% |
| Net sales 1 | 214,391 | 246,697 | 279,164 | 325,535 | 335,933 | 351,913 | 392,780 | 432,813 |
| EBITDA 1 | 51,400 | 64,559 | 79,481 | 86,236 | 67,048 | 62,054 | 80,052 | 91,743 |
| EBIT 1 | 34,277 | 52,057 | 64,781 | 69,178 | 46,443 | 41,610 | 57,480 | 67,249 |
| Net income 1 | 23,568 | 45,073 | 55,779 | 56,544 | 42,850 | 37,221 | 48,989 | 57,716 |
| Net Debt 1 | -10,520 | -48,325 | -64,586 | -24,535 | -32,714 | -31,582 | -51,618 | -82,055 |
| Reference price 2 | 861.08 | 924.30 | 1,231.03 | 1,144.05 | 1,254.65 | 1,177.80 | 1,177.80 | 1,177.80 |
| Nbr of stocks (in thousands) | 829,771 | 830,526 | 832,611 | 833,152 | 832,596 | 832,984 | - | - |
| Announcement Date | 5/19/22 | 5/10/23 | 5/7/24 | 5/9/25 | 5/12/26 | - | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 26.02x | 2.7x | 15.3x | 0.65% | 10.27B | ||
| 33.44x | 12.14x | 24.6x | 0.59% | 1,047B | ||
| 29.82x | - | - | 2% | 646B | ||
| 32.61x | 7.57x | 15.74x | 2.68% | 451B | ||
| 19.99x | 4.75x | 11.76x | 2.79% | 355B | ||
| 21.76x | 5.62x | 13.93x | 2.85% | 291B | ||
| 20.88x | 4.29x | 12.24x | 2.06% | 252B | ||
| 27.35x | 7.07x | 12.56x | 2.33% | 234B | ||
| 13.25x | 4.77x | 9.95x | 3.83% | 203B | ||
| -44.51x | 6.43x | 25.11x | 2.26% | 181B | ||
| Average | 18.06x | 6.15x | 15.69x | 2.2% | 366.95B | |
| Weighted average by Cap. | 24.25x | 8.05x | 17.80x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DRREDDY Stock
- Valuation Dr. Reddy's Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















